|Articles|April 20, 2021
Liposomal and Nanoparticle Technology
Author(s)Pfizer CentreOne
Specializing in oncology, anti-infective and complex formulations, Pfizer CentreOne provides end to end services from development through to commercial manufacture of sterile dosage forms.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
